Bolyn Hubby Joins Parker Institute for Cancer Immunotherapy as Chief of Staff

The Parker Institute for Cancer Immunotherapy has announced the appointment of Bolyn Hubby as Chief of Staff, reflecting a strategic alignment aimed at accelerating innovation, collaboration, and translational impact across the institute’s network.

Strengthening the Executive Leadership Structure

• Bolyn Hubby will serve as a central node connecting scientific, operational, and strategic priorities.
• She is expected to support integration of scientific discoveries into clinical advances.

Two Decades at the Intersection of Science and Strategy

• Bolyn Hubby brings extensive experience across biotechnology sectors, including infectious diseases, immunology, and oncology.
• She has held leadership roles at multiple companies, developing expertise in navigating regulatory environments, shaping public-private partnerships, and building strategic alliances.

A Vision Shared With OncoDaily

In a discussion with OncoDaily, Bolyn Hubby stated:

I’m honored to join the Parker Institute for Cancer Immunotherapy at such a pivotal moment in its evolution and look forward to advancing its mission by strengthening organizational alignment and accelerating the journey from discovery to meaningful patient impact.

Driving Impact in an Era of Complex Oncology Innovation

Cancer immunotherapy has entered a phase defined by complexity. Leadership roles that connect scientific discovery with operational execution are becoming indispensable. Hubby’s experience positions her to contribute meaningfully to PICI’s mission of transforming immunotherapy research into tangible patient benefit.

A Personal Mission Rooted in Experience

Beyond her formal remarks, Bolyn Hubby shared a deeply personal perspective in a LinkedIn post:

Forty-five years ago, an experimental immunotherapy gave my dad 40 years beyond a metastatic melanoma diagnosis. My sister is an 11-year cancer survivor. I got into biotech because I’ve seen what breakthroughs can do, and after 20+ years working at the intersection of science, strategy, and execution, PICI is exactly where I want to be.

PICI at Ten Years

As the Parker Institute approaches its ten-year milestone, the organization stands at a critical juncture. Over the past decade, it has established itself as a key driver of collaborative cancer research, bringing together leading institutions to accelerate the development of immunotherapy treatments.